ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,582.80
      -2.09%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.605
      0.22%
      Bitcoin
      63,860.00
      0.55%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cullinan Oncology Inc (CGEM)

      7. Cullinan Oncology Inc (CGEM) News

      CGEM Cullinan Oncology Inc

      15.66
      -2.40 (-13.29%)
      After Hours
      Last Updated: 16:08:51
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Cullinan Oncology Inc CGEM NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -2.40 -13.29% 15.66 16:08:51
      Open Price Low Price High Price Close Price Prev Close
      18.00 15.20 18.2599 15.72 18.06
      more quote information »

      Recent News

      Date Time Source Heading
      4/16/202407:00GLOBECullinan Therapeutics Announces Strategic Expansion into..
      4/16/202406:59GLOBECullinan Therapeutics Announces Oversubscribed $280 million..
      3/14/202407:00GLOBECullinan Oncology Provides Corporate Update and Reports..
      3/01/202407:00GLOBECullinan Oncology Announces U.S. FDA Clearance of..
      2/27/202408:00GLOBECullinan Oncology to Participate in Upcoming Investor..
      2/23/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/23/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/23/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202421:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/02/202421:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/01/202416:43EDGAR2Form 144 - Report of proposed sale of securities
      1/30/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202416:27EDGAR2Form 144 - Report of proposed sale of securities
      1/24/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202416:18EDGAR2Form 144 - Report of proposed sale of securities
      1/08/202416:15EDGAR2Form 8-K/A - Current report: [Amend]
      1/08/202409:12EDGAR2Form 8-K - Current report
      12/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202316:53GLOBECullinan Oncology to Present at the 42nd Annual J.P. Morgan..
      12/14/202316:30GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
      12/13/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/13/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202307:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202307:10EDGAR2Form 8-K - Current report
      11/08/202307:00GLOBECullinan Oncology Provides Corporate Update and Reports..
      11/03/202312:01GLOBECullinan Oncology to Present Data Demonstrating Progress..
      10/30/202308:00GLOBECullinan Oncology to Participate in Upcoming Investor..
      9/06/202308:00GLOBECullinan Oncology to Participate in Upcoming Investor..
      8/10/202307:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/10/202307:07EDGAR2Form 8-K - Current report
      8/10/202307:00GLOBECullinan Oncology Provides Corporate Update and Reports..
      8/09/202307:00GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
      8/03/202316:15PRNUSREZILIENT3 Global First-Line Trial of Zipalertinib Launched..
      7/31/202308:00GLOBECullinan Oncology to Participate in Upcoming Investor..
      7/05/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/25/202317:00GLOBECullinan Oncology to Present First Monotherapy Clinical Data..
      5/11/202316:01GLOBECullinan Oncology Provides Corporate Update and Reports..
      4/26/202310:08GLOBECullinan Oncology to Present First Clinical Data Evaluating..
      4/20/202307:00GLOBECullinan Oncology to Participate in Stifel’s 2023 Targeted..

      Your Recent History

      NASDAQ
      CGEM
      Cullinan Oncology
      Delayed Upgrade Clock